80
Participants
Start Date
May 19, 2010
Primary Completion Date
November 29, 2012
Study Completion Date
December 18, 2012
Cilostazol, Probucol
"Treatment Group 1 (control) No cilostazol or probucol~Treatment Group 2 (cilostazol alone) 1 tablet cilostazol 100 mg PO BID~Treatment Group 3 (probucol alone) 1 tablet probucol 250 mg PO BID~Treatment Group 4 (concomitant cilostazol and probucol) 1 tablet cilostazol 100 mg PO BID, and 1 tablet probucol 250 mg PO BID"
Asan Medical Center, Seoul
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
INDUSTRY